Overview Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD Status: Recruiting Trial end date: 2031-01-01 Target enrollment: Participant gender: Summary This study suggested that hydrogen has a potential as an effective and safe therapeutic agent on cGVHD. Phase: Phase 2 Details Lead Sponsor: Navy General Hospital, Beijing